BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36573458)

  • 21. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
    Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
    Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of Sonic hedgehog signaling pathway activity is involved in 5-fluorouracil-induced apoptosis and motility inhibition in Hep3B cells.
    Wang Q; Huang S; Yang L; Zhao L; Yin Y; Liu Z; Chen Z; Zhang H
    Acta Biochim Biophys Sin (Shanghai); 2008 Sep; 40(9):819-29. PubMed ID: 18776995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated LOXL2 expression by LINC01347/miR-328-5p axis contributes to 5-FU chemotherapy resistance of colorectal cancer.
    Zheng GL; Liu YL; Yan ZX; Xie XY; Xiang Z; Yin L; Wang QQ; Chong DC; Xue GL; Xu LL; Zhou K; Wang Q
    Am J Cancer Res; 2021; 11(4):1572-1585. PubMed ID: 33948374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5-FU.
    Sang J; Tang R; Yang M; Sun Q
    Biomed Res Int; 2020; 2020():9312149. PubMed ID: 32851092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-suppressive zinc finger protein 24 (ZNF24) sensitizes colorectal cancer cells to 5-fluorouracil by inhibiting the Wnt pathway and activating the p53 signaling.
    Meng F; Ai C; Yan G; Wang G
    Exp Cell Res; 2023 Dec; 433(1):113796. PubMed ID: 37774763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways.
    Hu Z; Long T; Ma Y; Zhu J; Gao L; Zhong Y; Wang X; Wang X; Li Z
    J Exp Clin Cancer Res; 2020 May; 39(1):76. PubMed ID: 32370786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RUNX1 regulates the proliferation and chemoresistance of colorectal cancer through the Hedgehog signaling pathway.
    Li Q; Lai Q; He C; Zhang H; Pan X; Li H; Yan Q; Fang Y; Liu S; Li A
    J Cancer; 2021; 12(21):6363-6371. PubMed ID: 34659526
    [No Abstract]   [Full Text] [Related]  

  • 29. PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway.
    Wei PL; Huang CY; Chang TC; Lin JC; Lee CC; Prince GMSH; Makondi PT; Chui AW; Chang YJ
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of circ_0004585 enhances the chemosensitivity of colorectal cancer cells to 5-fluorouracil via the miR-874-3p/CCND1 axis.
    Wang S; Cao J; Pei L
    Histol Histopathol; 2023 Jan; 38(1):99-112. PubMed ID: 35900059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA NEAT1 knockdown attenuates autophagy to elevate 5-FU sensitivity in colorectal cancer via targeting miR-34a.
    Liu F; Ai FY; Zhang DC; Tian L; Yang ZY; Liu SJ
    Cancer Med; 2020 Feb; 9(3):1079-1091. PubMed ID: 31802650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Jiedu Sangen decoction inhibits chemoresistance to 5-fluorouracil of colorectal cancer cells by suppressing glycolysis via PI3K/AKT/HIF-1α signaling pathway.
    Sun LT; Zhang LY; Shan FY; Shen MH; Ruan SM
    Chin J Nat Med; 2021 Feb; 19(2):143-152. PubMed ID: 33641785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of miR-650 leads to down-regulation of KISS1, a possible route involved in overcoming 5-FU resistance and induction of apoptosis in CRC cells in-vitro.
    Valizadeh M; Babaei E; Sharifi R; Yazdanbod A
    Mol Biol Rep; 2023 Aug; 50(8):6591-6599. PubMed ID: 37341919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circ_0007031 enhances tumor progression and promotes 5-fluorouracil resistance in colorectal cancer through regulating miR-133b/ABCC5 axis.
    He X; Ma J; Zhang M; Cui J; Yang H
    Cancer Biomark; 2020; 29(4):531-542. PubMed ID: 32865180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPOCK1 silencing decreases 5-FU resistance through PRRX1 in colorectal cancer.
    Qu YL; Liu XL; Zhao SY; Zhai XF
    Pathol Res Pract; 2022 Jun; 234():153895. PubMed ID: 35462225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of CREPT confers colorectal cancer sensitivity to fluorouracil.
    Kuang YS; Wang Y; Ding LD; Yang L; Wang Y; Liu SH; Zhu BT; Wang XN; Liu HY; Li J; Chang ZJ; Wang YY; Jia BQ
    World J Gastroenterol; 2018 Jan; 24(4):475-483. PubMed ID: 29398868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer.
    Ren Y; Deng R; Cai R; Lu X; Luo Y; Wang Z; Zhu Y; Yin M; Ding Y; Lin J
    Carcinogenesis; 2020 Dec; 41(12):1755-1766. PubMed ID: 32338281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
    Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
    J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated microRNA-23a Expression Enhances the Chemoresistance of Colorectal Cancer Cells with Microsatellite Instability to 5-Fluorouracil by Directly Targeting ABCF1.
    Li X; Li X; Liao D; Wang X; Wu Z; Nie J; Bai M; Fu X; Mei Q; Han W
    Curr Protein Pept Sci; 2015; 16(4):301-9. PubMed ID: 25929864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.